Evidence map›Paper›PMID 24586966›Full record

ArticlePloS one2014

Assessing the exoproteome of marine bacteria, lesson from a RTX-toxin abundantly secreted by Phaeobacter strain DSM 17395.

Emie Durighello, Joseph Alexander Christie-Oleza, Jean Armengaud

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. The Proteogenome of SymbioticMicroorganisms · 2022
    Article
  2. Article
  3. Article
  4. Exoproteome Analysis of the Seaweed PathogenFrontiers in microbiology · 2017
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Emie DurighelloCEA, DSV, IBEB, Lab Biochim System Perturb, Bagnols-sur-Cèze, France.
Joseph Alexander Christie-OlezaCEA, DSV, IBEB, Lab Biochim System Perturb, Bagnols-sur-Cèze, France.
Jean ArmengaudCEA, DSV, IBEB, Lab Biochim System Perturb, Bagnols-sur-Cèze, France.
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInstitute of Environmental Biology and Biotechnology · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria from the Roseobacter clade are abundant in surface marine ecosystems as over 10% of bacterial cells in the open ocean and 20% in coastal waters belong to this group. In order to document how these marine bacteria interact with their environment, we analyzed the exoproteome of Phaeobacter strain DSM 17395. We grew the strain in marine medium, collected the exoproteome and catalogued its content with high-throughput nanoLC-MS/MS shotgun proteomics. The major component represented 60% of the total protein content but was refractory to either classical proteomic identification or proteogenomics. We de novo sequenced this abundant protein with high-resolution tandem mass spectra which turned out being the 53 kDa RTX-toxin ZP_02147451. It comprised a peptidase M10 serralysin domain. We explained its recalcitrance to trypsin proteolysis and proteomic identification by its unusual low number of basic residues. We found this is a conserved trait in RTX-toxins from Roseobacter strains which probably explains their persistence in the harsh conditions around bacteria. Comprehensive analysis of exoproteomes from environmental bacteria should take into account this proteolytic recalcitrance.

Indexed as

Amino Acid SequenceElectrophoresis, Polyacrylamide GelMarine ToxinsMolecular Sequence DataProteomicsRhodobacteraceaeRoseobacterSeawaterTandem Mass SpectrometryTrypsinMarine ToxinsTrypsin

Identifiers

PMID24586966
PMCPMC3933643
OpenAlexW2046441867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.